Literature DB >> 180200

Effect of human exogenous leukocyte interferon in cytomegalovirus infections.

G Emödi, R O'Reilly, A Müller, L K Everson, U Binswanger, M Just.   

Abstract

Human leukocyte interferon was injected into nine patients with cytomegalovirus infections; four of these patients were congenitally infected, and five had acquired infections. In three patients viruria was completely inhibited. In five patients viral excretion in the urine was only transiently inhibited. Viremia was not significantly suppressed. The lymphocyte response to phytohemagglutinin was suppressed in two patients.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 180200     DOI: 10.1093/infdis/133.supplement_2.a199

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  17 in total

Review 1.  Herpesviruses.

Authors:  M C Timbury; E Edmond
Journal:  J Clin Pathol       Date:  1979-09       Impact factor: 3.411

Review 2.  The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus.

Authors:  Lisi Amsler; Marieke Verweij; Victor R DeFilippis
Journal:  J Mol Biol       Date:  2013-09-05       Impact factor: 5.469

3.  Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex.

Authors:  E R Kern; G A Olsen; J C Overall; L A Glasgow
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

Review 4.  Cell-mediated immunity and its role in resistance to infection.

Authors:  E J Wing; J S Remington
Journal:  West J Med       Date:  1977-01

Review 5.  Interferon: therapeutic fact or fiction for the '80s?

Authors:  G M Scott; D A Tyrrell
Journal:  Br Med J       Date:  1980-06-28

Review 6.  Interferon therapy: pharmacokinetic and pharmacological aspects.

Authors:  A Billiau
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

Review 7.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

8.  Susceptibility of clinical isolates of cytomegalovirus to human interferon.

Authors:  B Postic; J N Dowling
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

9.  Protective effect of low-dose interferon against neonatal murine cytomegalovirus infection.

Authors:  J R Cruz; G J Dammin; J L Waner
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice.

Authors:  G A Olsen; E R Kern; L A Glasgow; J C Overall
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.